Skip links

CBD-Intel

Your one-stop source of market and regulatory strategic data for the CBD industry

Start your FREE trial now

FREE TRIAL

*Trial version includes access to news analysis only.

Our business

CBD-Intel provides premium market and regulatory analysis, legal tracking, and quantitative data for the cannabidiol (CBD) sector, with a focus on non-US markets.

We provide our clients with the tools to navigate this fast-moving sector, tailor their business strategy, optimise resources and make informed decisions.

OUR SERVICES

Our platform

Providing all the data in one online platform reduces the amount of time and money spent monitoring the sector for multiple international markets.

Our global perspective on the international CBD sector offers you key data such as market trends, key players, regulatory obligations and industry dynamics. You will also have access to:

  • Competitor intelligence, pricing, distribution and detailed market data
  • Industry updates and news analysis including our expert insights
  • Legal and regulatory analysis included in our in-depth reports
  • Regular updates delivered directly to your inbox to make sure you don’t miss any important changes in the industry.

FREE TRIAL

The CBD Intel Crew

Our team

CBD-Intel’s team is made up by a leading group of lawyers, economists and journalists. The team is based between London, Barcelona and Washington DC, along with correspondents and contributors from around the world.

We are wholly independent of the sector, giving you access to frank and objective analysis that may not be available to other industry participants.

WHO WE ARE

FAQ

What isn’t CBD-Intel?
It isn’t a hobby/enthusiast site for CBD fans. It isn’t a pro- or anti-CBD site. It isn’t a mouthpiece for the industry. It isn’t a CBD store.
Who owns CBD-Intel?
CBD-Intel is owned and operated by Tamarind Media Ltd., a privately-held company registered in the UK.
What platforms is CBD-Intel available through?
Our website is designed to be usable in all major browsers on all major platforms, including mobile and tablet. If you have a problem using it, please let us know, giving details of the exact issue and your setup.
Do the members of your team use CBD?
We don’t know; that’s their business.
How do I subscribe?
Please visit our subscriptions page for more information.
What is your editorial position on CBD regulation?
We strive to be impartial and objective, which means we don’t take pro- or anti- positions on particular regulatory issues (though our contributors are free to have, and express, their personal views). We do believe that regulation – whatever stance it takes – should be fair and reasonable, and we hope to encourage this by fostering debate among all the many stakeholders concerned with regulating the CBD industry.
Reports screen sample

All you need to know about CBD in one place

SIGN UP